156 related articles for article (PubMed ID: 10331241)
1. Studies on the interactions between human serum albumin and imidazolium [trans-tetrachlorobis(imidazol)ruthenate(III)].
Trynda-Lemiesz L; Keppler BK; Kozłowski H
J Inorg Biochem; 1999 Mar; 73(3):123-8. PubMed ID: 10331241
[TBL] [Abstract][Full Text] [Related]
2. Studies on the interactions between human serum albumin and trans-indazolium (bisindazole) tetrachlororuthenate(III).
Trynda-Lemiesz L; Karaczyn A; Keppler BK; Kozłowski H
J Inorg Biochem; 2000 Mar; 78(4):341-6. PubMed ID: 10857915
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-HSA interaction. Binding sites on HSA molecule.
Trynda-Lemiesz L
Bioorg Med Chem; 2004 Jun; 12(12):3269-75. PubMed ID: 15158795
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the binding sites of the anticancer ruthenium(III) complexes KP1019 and KP1339 on human serum albumin via competition studies.
Dömötör O; Hartinger CG; Bytzek AK; Kiss T; Keppler BK; Enyedy EA
J Biol Inorg Chem; 2013 Jan; 18(1):9-17. PubMed ID: 23076343
[TBL] [Abstract][Full Text] [Related]
5. Studies on the interaction between human serum albumin and [Rh2(OAc)2(bpy)2(H2O)2](OAc)2.
Trynda-Lemiesz L; Pruchnik FP
J Inorg Biochem; 1997 May; 66(3):187-92. PubMed ID: 9130393
[TBL] [Abstract][Full Text] [Related]
6. Exploring the interaction between picoplatin and human serum albumin: The effects on protein structure and activity.
Wang Y; Wu P; Zhou X; Zhang H; Qiu L; Cao J
J Photochem Photobiol B; 2016 Sep; 162():611-618. PubMed ID: 27484966
[TBL] [Abstract][Full Text] [Related]
7. New advances in the study on the interaction of [Cr(phen)2(dppz)]3+ complex with biological models; association to transporting proteins.
Toneatto J; Argüello GA
J Inorg Biochem; 2011 May; 105(5):645-51. PubMed ID: 21450267
[TBL] [Abstract][Full Text] [Related]
8. Interactions of human serum albumin with meloxicam: characterization of binding site.
Trynda-Lemiesz L; Wiglusz K
J Pharm Biomed Anal; 2010 Jun; 52(2):300-4. PubMed ID: 20089378
[TBL] [Abstract][Full Text] [Related]
9. Five recombinant fragments of human serum albumin-tools for the characterization of the warfarin binding site.
Dockal M; Chang M; Carter DC; Rüker F
Protein Sci; 2000 Aug; 9(8):1455-65. PubMed ID: 10975567
[TBL] [Abstract][Full Text] [Related]
10. Role of salt bridge(s) in the binding and photoconversion of bilirubin bound to high affinity site on human serum albumin.
Khan MM; Muzammil S; Tayyab S
Biochim Biophys Acta; 2000 Jun; 1479(1-2):103-13. PubMed ID: 11004533
[TBL] [Abstract][Full Text] [Related]
11. The binding properties of two antitumor ruthenium(III) complexes to apotransferrin.
Kratz F; Hartmann M; Keppler B; Messori L
J Biol Chem; 1994 Jan; 269(4):2581-8. PubMed ID: 8300587
[TBL] [Abstract][Full Text] [Related]
12. Control of ligand-exchange processes and the oxidation state of the antimetastatic Ru(III) complex NAMI-A by interactions with human serum albumin.
Webb MI; Walsby CJ
Dalton Trans; 2011 Feb; 40(6):1322-31. PubMed ID: 21210063
[TBL] [Abstract][Full Text] [Related]
13. X-ray Structure Analysis of Indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019) Bound to Human Serum Albumin Reveals Two Ruthenium Binding Sites and Provides Insights into the Drug Binding Mechanism.
Bijelic A; Theiner S; Keppler BK; Rompel A
J Med Chem; 2016 Jun; 59(12):5894-903. PubMed ID: 27196130
[TBL] [Abstract][Full Text] [Related]
14. Binding of heme to human serum albumin: steady-state fluorescence, circular dichroism and optical difference spectroscopic studies.
Kamal JK; Behere DV
Indian J Biochem Biophys; 2005 Feb; 42(1):7-12. PubMed ID: 23923575
[TBL] [Abstract][Full Text] [Related]
15. Effect of ibuprofen and warfarin on the allosteric properties of haem-human serum albumin. A spectroscopic study.
Baroni S; Mattu M; Vannini A; Cipollone R; Aime S; Ascenzi P; Fasano M
Eur J Biochem; 2001 Dec; 268(23):6214-20. PubMed ID: 11733017
[TBL] [Abstract][Full Text] [Related]
16. CF3 Derivatives of the Anticancer Ru(III) Complexes KP1019, NKP-1339, and Their Imidazole and Pyridine Analogues Show Enhanced Lipophilicity, Albumin Interactions, and Cytotoxicity.
Chang SW; Lewis AR; Prosser KE; Thompson JR; Gladkikh M; Bally MB; Warren JJ; Walsby CJ
Inorg Chem; 2016 May; 55(10):4850-63. PubMed ID: 27143338
[TBL] [Abstract][Full Text] [Related]
17. Binding of an anticancer drug, axitinib to human serum albumin: Fluorescence quenching and molecular docking study.
Tayyab S; Izzudin MM; Kabir MZ; Feroz SR; Tee WV; Mohamad SB; Alias Z
J Photochem Photobiol B; 2016 Sep; 162():386-394. PubMed ID: 27424099
[TBL] [Abstract][Full Text] [Related]
18. Study on the interaction of the epilepsy drug, zonisamide with human serum albumin (HSA) by spectroscopic and molecular docking techniques.
Shahabadi N; Khorshidi A; Moghadam NH
Spectrochim Acta A Mol Biomol Spectrosc; 2013 Oct; 114():627-32. PubMed ID: 23811149
[TBL] [Abstract][Full Text] [Related]
19. Impact of K2PtCl4 on the structure of human serum albumin and its binding ability of heme and bilirubin.
Trynda L; Kuduk-Jaworska J
J Inorg Biochem; 1994 Mar; 53(4):249-60. PubMed ID: 8169606
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the binding of cis/trans-[MCl4(1H-indazole)(NO)](-) (M = Ru, Os) complexes to human serum albumin.
Dömötör O; Rathgeb A; Kuhn PS; Popović-Bijelić A; Bačić G; Enyedy EA; Arion VB
J Inorg Biochem; 2016 Jun; 159():37-44. PubMed ID: 26908285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
